Cargando…

Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system. Recent developments have led to newer therapeutic options for disease treatment. A few studies have reported MS prevalence rates between 12 and 20 per 100,000 inhabitants nationwide in Argentina, and an incidence of 1.76...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rojas, Juan I, Patrucco, Liliana, Cristiano, Edgardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337150/ https://www.ncbi.nlm.nih.gov/pubmed/32669904 http://dx.doi.org/10.2147/DNND.S46557

Ejemplares similares

Family planning in Argentinian women with multiple sclerosis: An important yet seldom approached issue
por: Alonso, Ricardo, et al.
Publicado: (2021)

Influenza vaccination status in multiple sclerosis patients from Latin America
por: Rojas, Juan I., et al.
Publicado: (2021)

Brain volume loss and physical and cognitive impairment in naïve multiple sclerosis patients treated with fingolimod: prospective cohort study in Buenos Aires, Argentina
por: Rojas, Juan Ignacio, et al.
Publicado: (2022)

Multiple sclerosis epidemiology in Latin America: An updated survey
por: Cristiano, Edgardo, et al.
Publicado: (2017)

Estimating the risk of COVID-19 in multiple sclerosis patients in Buenos Aires, Argentina
por: Cristiano, E, et al.
Publicado: (2020)

Real-world effectiveness of natalizumab treatment in patients with relapsing multiple sclerosis in Argentina and Chile
por: Ysrraelit, Maria Celica, et al.
Publicado: (2021)

Real-world experience of ocrelizumab in multiple sclerosis patients in Latin America
por: ROJAS, Juan Ignacio, et al.
Publicado: (2021)

Natalizumab for the treatment of relapsing multiple sclerosis
por: Rudick, Richard A, et al.
Publicado: (2008)

Ponesimod in the Treatment of Relapsing Forms of Multiple Sclerosis: An Update on the Emerging Clinical Data
por: Ruggieri, Serena, et al.
Publicado: (2022)

The genetics of multiple sclerosis: review of current and emerging candidates
por: Muñoz-Culla, Maider, et al.
Publicado: (2013)

The Argentinian landscape of mycological diagnostic capacity and treatment accessibility
por: Riera, Fernando, et al.
Publicado: (2023)

Briumvi: a breakthrough in the treatment of relapsing multiple sclerosis: a review
por: Azhar, Ayesha, et al.
Publicado: (2023)

Dengue emergence in the temperate Argentinian province of Santa Fe, 2009–2020
por: López, María S., et al.
Publicado: (2021)

Current and Emerging Therapies for the Treatment of Multiple Sclerosis: Focus on Cladribine
por: Schreiner, Teri L., et al.
Publicado: (2012)

Current and emerging disease‐modulatory therapies and treatment targets for multiple sclerosis
por: Piehl, F.
Publicado: (2020)

Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
por: Paolicelli, Damiano, et al.
Publicado: (2009)

Review of daclizumab and its therapeutic potential in the treatment of relapsing–remitting multiple sclerosis
por: Reardon, Jennifer, et al.
Publicado: (2013)

Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis
por: Guarnera, Cristina, et al.
Publicado: (2017)

Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs—A Systematic Review
por: Rolfes, Leoni, et al.
Publicado: (2019)

Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies
por: Coret, Francisco, et al.
Publicado: (2018)

Natalizumab: A new treatment for relapsing remitting multiple sclerosis
por: Hutchinson, Michael
Publicado: (2007)

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
por: Lugaresi, Alessandra, et al.
Publicado: (2013)

An Overview of the Efficacy and Safety of Ozanimod for the Treatment of Relapsing Multiple Sclerosis
por: Fronza, Marzia, et al.
Publicado: (2021)

Treatment of relapsing multiple sclerosis – recommendations of the Croatian Neurological Society
por: Habek, Mario, et al.
Publicado: (2022)

Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse
por: Mills, Elizabeth A., et al.
Publicado: (2017)

Current and Emerging Treatment Options for Patients with Relapsed Myeloma
por: Castelli, Roberto, et al.
Publicado: (2013)

Behcet Disease in pediatric Argentinian patients
por: Meiorin, S, et al.
Publicado: (2015)

Genetic admixture patterns in Argentinian Patagonia
por: Parolin, María Laura, et al.
Publicado: (2019)

Color Source for the First Argentinian Flags
por: Picone, A. Lorena, et al.
Publicado: (2019)

Factors Involved in Relapse of Multiple Sclerosis
por: Kamel, Fatemah Omar
Publicado: (2019)

The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
por: Hermann, Robert, et al.
Publicado: (2018)

Advances in the treatment of relapsing—remitting multiple sclerosis — critical appraisal of fingolimod
por: Gasperini, Claudio, et al.
Publicado: (2013)

Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
por: Cocco, Eleonora, et al.
Publicado: (2015)

Teriflunomide for the treatment of relapsing–remitting multiple sclerosis: patient preference and adherence
por: Bayas, Antonios, et al.
Publicado: (2015)

The innovative development in interferon beta treatments of relapsing‐remitting multiple sclerosis
por: Madsen, Claus
Publicado: (2017)

Emerging therapies for treatment of multiple sclerosis
por: Corboy, John R, et al.
Publicado: (2010)

Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives
por: Tryfonos, Christina, et al.
Publicado: (2019)

Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review
por: Giovannoni, Gavin, et al.
Publicado: (2022)

Current and emerging treatments for amyotrophic lateral sclerosis
por: Zoccolella, Stefano, et al.
Publicado: (2009)

Abstracts From the Argentinian Society of Osteology and Mineral Metabolism (AAOMM) and Argentinian Society of Osteoporosis (SAO) 2020 Annual Meeting
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1117nn9tljcnqiik1hejf4dfit